IP Library Granted Patent US 11,161,827
Granted Patent B2
US 11,161,827 · App. 16/840,879 · Granted Nov 2, 2021

Catalytic systems for stereoselective synthesis of chiral amines by enantiodivergent radical C—H amination

Inventors: Xiao-Xiang Zhang (Newton, MA); Kai Lang (Boston, MA)
Assignee: The Trustees of Boston College
C07D285/10B01J31/183C07D487/22B01J2231/4283B01J2531/845
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,161,827
App. No.
16/840,879
Granted
Nov 2, 2021
Kind
B2
Abstract

In one aspect, the disclosure relates to a mode of asymmetric induction in radical processes based on sequential combination of enantiodifferentiative H-atom abstraction and stereoretentive radical substitution. Also disclosed is an asymmetric system for stereoselective synthesis of strained 5-membered cyclic sulfamides via radical 1,5-C—H amination of sulfamoyl azides. The disclosed metalloradical system can control the degree and sense of asymmetric induction in the catalytic radical C—H amination in a systematic manner. The disclosed system is applicable to a broad scope of substrates with different types of C(sp 3 )—H bonds and exhibits reactivity and selectivity, providing access to both enantiomers of useful 5-membered cyclic sulfamides in a highly enantioenriched form. Also disclosed are catalysts useful in these processes. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

Claims (17)

1. A catalyst for the stereoselective synthesis of chiral sulfamides, the catalyst having Formula I:

wherein M comprises cobalt;

wherein m is 1;

wherein R 1 is selected from

and

wherein each R 2 and R 2 ′ is independently —CH 2 — and each R 2 is chemically linked to an adjoining R 2 ′ with a bridge having a structure

wherein n is 0, 2, 4, or 6.

2. The catalyst of claim 1 , wherein n is 4 and R 1 is

3. The catalyst of claim 1 , wherein n is 2 and R 1 is

4. A method for the stereoselective synthesis of a chiral sulfamide, the method comprising contacting a sulfamoyl azide substrate with the catalyst of claim 1 in a solvent.

5. The method of claim 4 , wherein the solvent comprises methyl tert-butyl ether (MTBE).

6. The method of claim 4 , wherein the substrate has Formula II:

wherein R 3 is a benzoyl group, and

wherein R 4 is selected from:

or wherein R 3 is —(CH 2 ) 3 -Ph and R 4 is -Ph.

7. The method of claim 6 , wherein the chiral sulfamide consists of the following structures:

8. The method of claim 7 , wherein the ratio of (R) enantiomer at * to (S) enantiomer at * is from about 4:96 to about 99:1.

Assignments (3)
MERGER Recorded Dec 20, 2023
From: PCS FERGUSON, INC.
To: CHAMPIONX LLC
Reel/Frame 065925/0893 →
CONFIRMATORY LICENSE Recorded May 19, 2020
From: BOSTON COLLEGE OFFICE OF TECHNOLOGY TRANSFER AND LICENSING
To: NATIONAL INSTITUTES OF HEALTH, U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, U.S. GOVERNMENT
Reel/Frame 052700/0954 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2020
From: ZHANG, XIAO-XIANG; LANG, KAI
To: THE TRUSTEES OF BOSTON COLLEGE
Reel/Frame 052320/0861 →
Continuity (2)
Provisional Application 62829713 · Apr 5, 2019
Related Publication 20200317627A1 · Oct 8, 2020